✦ LIBER ✦

Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial

✍ Scribed by Katalin Boér; István L↭g; Éva Juhos; Tamás Pintér; János Szántó

Book ID: 105699431
Publisher: Springer Netherlands
Year: 2003
Tongue: English
Weight: 765 KB
Volume: 9
Category: Article
ISSN: 1219-4956
DOI: 10.1007/bf03033731

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of body mass index on overall

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

✍ Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 307 KB

Randomized trial to evaluate the additio

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

✍ James N. Ingle; Lloyd K. Everson; H. Sam Wieand; Stephen A. Cullinan; Lester E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Safety of zoledronic acid and incidence

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

✍ R. Coleman; E. Woodward; J. Brown; D. Cameron; R. Bell; D. Dodwell; M. Keane; M. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 339 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views